India has introduced stricter rules for the sale of syrup-based medicines, a move that is expected to affect cough syrups, tonics and several other liquid formulations sold through medical stores across the country.
The decision is aimed at improving drug safety, reducing misuse and increasing accountability in the medicine supply chain. It follows growing concerns around the unregulated sale of certain liquid medicines, including cough syrups that may be misused or consumed without medical advice.
Under the revised rules, “syrup” has been removed from the exemption list under Schedule K of the Drugs Rules, 1945. This means liquid syrup medicines that were earlier allowed to be sold more freely under the exemption may now come under tighter retail control.
The change does not automatically mean that every syrup in India has been placed under Schedule H1. However, it does mean that medical stores, pharmacists and consumers will need to pay closer attention to the classification and label of each medicine before purchase or sale.
The government notification was issued in June 2026 and amended the Drugs Rules, 1945 by removing the word “syrup” from the Schedule K exemption list.
Schedule K is a list of medicines that are exempt from some provisions of the Drugs Rules. Earlier, certain syrup formulations could be sold under this exemption. After the amendment, syrup medicines no longer receive the same blanket exemption.
This is likely to increase the role of pharmacists and registered medical practitioners in the sale of liquid medicines.
The decision is particularly important for cough syrups, tonics, paediatric syrups and other oral liquid formulations. Many families in India buy such products directly from medical stores for cough, cold, fever, digestion, weakness and seasonal illness.
In several cases, people begin using syrup medicines without consulting a doctor. Some consumers may also continue using the same syrup for longer than recommended or give adult medicines to children without proper advice.
Health experts have repeatedly warned that self-medication can be risky, especially for children, elderly people, pregnant women and patients with liver, kidney or heart conditions.
Some cough syrups contain ingredients that can cause drowsiness, affect breathing or interact with other medicines. Certain formulations may also contain alcohol or substances that should not be used without medical guidance.
The latest rule change is expected to make the sale process more controlled, especially for medicines that carry warnings or require professional advice.
There has also been discussion about medicines containing a higher percentage of alcohol. Some tonics and cough preparations contain alcohol as a solvent or ingredient. These medicines may require more careful handling because alcohol-containing formulations can be misused.
However, consumers should not assume that every syrup with alcohol content has automatically been placed in Schedule H1. The exact legal classification depends on the medicine, its ingredients, the approved label and the applicable drug rules.
Schedule H1 is a stricter category under the Drugs Rules. Medicines listed under Schedule H1 can only be sold against a valid prescription from a registered medical practitioner.
Pharmacies are also required to maintain a separate record of sales for Schedule H1 medicines. The record generally includes details such as the patient’s name, doctor’s prescription, quantity sold and date of sale.
The government recently added Pregabalin and its formulations to Schedule H1, citing concerns about misuse and unauthorised sale. The rules require pharmacies to maintain records and ensure that the medicine is sold only with a valid prescription.
Pregabalin is used for certain nerve-related pain conditions, seizures and other medical problems. But it has also been linked to misuse because it can produce sedative effects in some people.
The inclusion of Pregabalin in Schedule H1 shows the government’s broader approach toward tightening control over medicines that may be misused.
For medical-store owners, the latest changes may mean greater responsibility. Pharmacists will need to check medicine labels carefully and ensure that prescription-only drugs are not sold without proper documentation.
Medical stores may also need to maintain more detailed registers for medicines covered under strict schedules. Failure to follow drug-sale rules can lead to legal action under the Drugs and Cosmetics Act and related rules.
The change may also affect small chemist shops in towns and villages where people often buy medicines directly without visiting a doctor.
Many people prefer buying cough syrup or fever syrup from a nearby pharmacy because it is faster and less expensive than visiting a clinic. But the government’s move suggests that safety concerns are now being given greater importance.
For patients, the main message is simple: check whether a medicine requires a prescription before buying it.
If a pharmacist asks for a doctor’s prescription for a syrup, consumers should not treat it as an unnecessary delay. The requirement may be linked to the medicine’s ingredients, safety warning or legal classification.
Parents should be especially careful while buying syrups for children. Children should not be given adult cough syrups, sleep medicines or strong cold medicines without medical advice.
The dose of a medicine depends on age, weight, health condition and other medicines being taken by the patient. A small dosing mistake can create serious health risks.
People should also avoid mixing cough syrups with alcohol, sleeping tablets or other sedative medicines. This can increase drowsiness and may affect breathing in some cases.
Another concern is the sale of fake or poor-quality medicines. Consumers should always buy medicines from licensed pharmacies and check the batch number, expiry date, manufacturer details and packaging.
If a syrup bottle looks damaged, has an unusual smell, has changed colour or does not have a proper label, it should not be used.
The government’s tighter rules may also help authorities track suspicious sales patterns. If a medicine is being sold in unusually high quantities, officials may be able to investigate whether it is being misused or diverted into illegal markets.
The move is part of a wider effort to improve medicine safety in India. Drug regulation is important because medicines can save lives when used correctly but can also cause harm when taken without proper guidance.
The revised rules are likely to bring some inconvenience for people who are used to buying syrups directly from medical stores. But the long-term aim is to reduce misuse, improve accountability and ensure that medicines are used under proper medical supervision.
For consumers, the safest approach is to consult a doctor or qualified pharmacist before buying any cough syrup, tonic or liquid medicine—especially if it is for a child, an elderly person or someone with an existing health condition.